At this time point, levels of IFN-γ, TNF and IL-4 were significantly lower in mice treated with BC-DETC (Fig. 5B), a finding than can be associated with the milder inflammatory reaction observed (Fig. 4A). Here, IL4 is linked to breast cancer.